Professor Robert Louis Wilensky
Hospital of the University of Pennsylvania, Philadelphia (United States of America)
Follow
Contributor content
Journal
A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction
11 December 2007
Journal
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction
1 March 2006
